Gastric Ulcer
📧 Sign up to get email alerts when something new happens for Gastric Ulcer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-03-23Clinical Trial Update: Esomeprazole Plus Sucralfate for Post-ESD Ulcer Healing [Phase 4]
Phase 4 clinical trial evaluating esomeprazole plus sucralfate for healing ulcers after endoscopic submucosal dissection in gastric neoplasm…
-
FDA approval · 2026-03-11FDA Approved: BERKLEY AND JENSEN OMEPRAZOLE — Supplemental Application (BJWC)
The FDA approved a supplemental application for Berkley and Jensen Omeprazole (omeprazole) submitted by BJWC.
-
FDA approval · 2026-03-11FDA Approved: EQUATE LANSOPRAZOLE — Supplemental Application (Wal-Mart Stores Inc)
FDA approved a supplemental application for Equate Lansoprazole (lansoprazole) by Wal-Mart Stores Inc, enabling the store-brand generic prot…
-
CLINICAL_TRIALS trial_result · 2026-03-04Clinical Trial Update: A Study of Esomeplazole (D961H) in Japanese Paediatric Patients With Reflux Esophagitis, Gastric Ulcer or Duodenal Ulcer [Phase 3]
A Phase 3 trial of Esomeplazole (D961H) in Japanese pediatric patients with reflux esophagitis, gastric ulcer, or duodenal ulcer has complet…
-
FDA approval · 2026-02-12FDA Approved: PEPCID AC MAXIMUM STRENGTH — Supplemental Application (Kenvue Brands LLC)
FDA approved a supplemental application for Pepcid AC Maximum Strength, a famotidine-containing product from Kenvue Brands LLC.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-02-11Clinical Trial Update: Compare and Evaluate the Safety and PK Data of a Single Dose Administration of 'AD-115A' or 'AD-1151' [Phase 1]
This Phase 1 trial update compares the safety and single-dose pharmacokinetics of two investigational drugs, AD-115A and AD-1151, in partici…
-
FDA approval · 2026-01-05FDA Approved: SUCRALFATE ORAL SUSPENSION — Original Application (Glenmark Pharmaceuticals Inc., USA)
FDA approved Glenmark's generic sucralfate oral suspension via Original Application (ANDA) to provide the same indications as the reference …
-
FDA approval · 2025-12-10FDA Approved: OMEPRAZOLE AND SODIUM BICARBONATE — Original Application (ANI Pharmaceuticals, Inc.)
FDA approved ANI Pharmaceuticals' original application for a generic omeprazole and sodium bicarbonate combination product.
-
CLINICAL_TRIALS trial_result · 2025-10-16Clinical Trial Update: The Use of Indocyanine Green to Visualize Blood Flow to the Gastrojejunostomy During Bariatric Surgery. [Phase 4]
Phase 4 clinical trial evaluating the use of indocyanine green to visualize blood flow to the gastrojejunostomy during bariatric surgery. Th…
-
FDA approval · 2025-10-03FDA Approved: GOOD NEIGHBOR PHARMACY OMEPRAZOLE — Supplemental Application (Amerisource Bergen)
The FDA approved a supplemental application for Good Neighbor Pharmacy Omeprazole (omeprazole) submitted by Amerisource Bergen.
-
CLINICAL_TRIALS trial_result · 2025-10-03Clinical Trial Update: The Study Compare and Evaluate the Safety and PK Data of a Single Dose Administration of 'AD-115A' or 'AD-1151' [Phase 1]
Phase 1 study updating safety and pharmacokinetics data comparing single-dose administration of AD-115A and AD-1151 in gastric ulcer.
-
CLINICAL_TRIALS trial_result · 2025-08-19Clinical Trial Update: Ulcer Pomegranate Muffins [NA]
Clinical trial on ulcer-related outcomes using pomegranate muffins sponsored by the University of Lahore has completed.
-
FDA approval · 2025-08-15FDA Approved: LANSOPRAZOLE — Supplemental Application (Ajanta Pharma USA Inc.)
FDA approves Ajanta Pharma USA Inc.'s supplemental application to market generic lansoprazole.
-
CLINICAL_TRIALS research · 2025-08-05Clinical Trial Update: Marginal Ulcer Healing With Low-Thermal Argon Plasma Endoscopic Treatment [NA]
A clinical trial evaluating healing of marginal ulcers after Roux-en-Y procedures using low-thermal argon plasma endoscopic therapy; current…
-
FDA approval · 2025-07-16FDA Approved: FAMOTIDINE — Original Application (Sagent Pharmaceuticals)
FDA approved the original application for famotidine from Sagent Pharmaceuticals, marking the approval of a generic product.
-
FDA approval · 2025-07-09FDA Approved: FAMOTIDINE — Original Application (Aurobindo Pharma Limited)
FDA approved the original abbreviated new drug application (ANDA) for famotidine from Aurobindo Pharma Limited, a generic version of famotid…
-
CLINICAL_TRIALS research · 2025-07-09Clinical Trial Update: Capsule Gastric Endoscopy for Gastric Disease Screening in Simulated Home Scenarios [NA]
A clinical trial evaluating capsule gastric endoscopy for screening gastric diseases in simulated home scenarios is currently recruiting.
-
CLINICAL_TRIALS research · 2025-07-04Clinical Trial Update: A Cohort Study of Mobile Capsule Gastroscopy for Gastric Pathologies Screening
An ongoing cohort study assessing mobile capsule gastroscopy for screening gastric pathologies at Nanfang Hospital/Southern Medical Universi…
-
CLINICAL_TRIALS research · 2025-06-06Clinical Trial Update: Functional Changes in the Stomach and Esophagus After One Anastomosis Gastric Bypass- OAGB [NA]
This ClinicalTrials.gov entry documents a study evaluating functional changes in the stomach and esophagus after One Anastomosis Gastric Byp…
-
FDA approval · 2025-06-02FDA Approved: FAMOTIDINE — Original Application (Lannett Company, Inc.)
FDA approved the original ANDA for famotidine from Lannett Company, Inc., establishing a generic version of famotidine.
-
FDA approval · 2025-05-16FDA Approved: PANTOPRAZOLE SODIUM — Original Application (Devatis Inc.)
FDA approves Pantoprazole Sodium as an Original Application generic product from Devatis Inc. under ANDA 215074.
-
CLINICAL_TRIALS research · 2025-05-15Clinical Trial Update: The Bioavailability and Effect on Pouch pH of Esomeprazole After Gastric Bypass [Phase 4]
Phase 4 study assessing the bioavailability of esomeprazole and its effect on pouch pH after gastric bypass; the trial is currently recruiti…
-
FDA approval · 2025-05-07FDA Approved: PANTOPRAZOLE SODIUM I.V. — Supplemental Application (Sandoz Inc)
FDA approved a supplemental application for pantoprazole sodium intravenous formulation from Sandoz Inc., expanding the product to include I…
-
FDA label_change · 2025-04-25FDA Approved: PANTOPRAZOLE SODIUM — Supplemental Application (Eugia US LLC)
FDA approved a supplemental application for pantoprazole sodium by Eugia US LLC, resulting in a labeling update for the product.
-
FDA approval · 2025-04-15FDA Approved: ESOMEPRAZOLE MAGNESIUM — Original Application (Aurobindo Pharma Limited)
FDA approved the original application for esomeprazole magnesium from Aurobindo Pharma Limited, enabling its marketing as a generic drug in …